Method of treatment and pharmaceutical composition

Details for Australian Patent Application No. 2003200032 (hide)

International Classifications

Event Publications

23 January 2003 Complete Application Filed

10 April 2003 Application Open to Public Inspection

Published as AU-B-2003200032

2 March 2006 Application Accepted

Published as AU-B-2003200032

29 June 2006 Standard Patent Sealed

14 April 2011 Section 223 Application Received

Novartis AG An application to extend the time from 05 Aug 2008 to 05 Nov 2010 in which to file an Extension of Term request has been filed . Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000 2008

2 June 2011 Section 223 Application Allowed

Novartis AG The time in which to file an Extension of Term request has been extended to 05 Nov 2010. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000 2008

16 June 2011 Extension of Term of Standard Patents

Novartis AG The earliest first regulatory approval date provided by the patentee 05 Feb 2011 For the goods EXFORGE 5/80

7 July 2011 Extension of Term of Standard Patents

Novartis AG The earliest first regulatory approval date provided by the patentee 05 Feb 2011 For the goods EXFORGE 5/80 Address for service in Australia: Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

1 December 2011 Extension granted

Novartis AG The earliest first regulatory approval date provided by the patentee 05 Feb 2011 For the goods EXFORGE 5/80 Extension of Term of patent pursuant to Section 77 expires on 05 Feb 2023

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.